Amelioration of DSS-Induced Acute Colitis in Mice by Recombinant Monomeric Human Interleukin-22

키워드

참고문헌 (61)

1. Ouyang W, "IL-10 family cytokines IL-10 and IL-22 : from basic science to clinical translation", Immunity, 50, pp.871~891 (2019)
2. Xie MH, "Interleukin(IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R", J Biol Chem, 275, pp.31335~31339 (2000)
3. Logsdon NJ, "Comparison of interleukin-22 and interleukin-10soluble receptor complexes", J Interferon Cytokine Res, 22, pp.1099~1112 (2002)
4. Nagem RA, "Crystal structure of recombinant human interleukin-22", Structure, 10, pp.1051~1062 (2002)
5. Dudakov JA, "Interleukin-22 : immunobiology and pathology", Annu Rev Immunol, 33, pp.747~785 (2015)
6. Colonna M, "Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity", Immunity, 31, pp.15~23 (2009)
7. Jones BC, "Structure of IL-22 bound to its high-affinity IL-22R1 chain", Structure, 16, pp.1333~1344 (2008)
8. Parks OB, "Interleukin-22 signaling in the regulation of intestinal health and disease", Front Cell Dev Biol, 3, pp.85~ (2016)
9. Lejeune D, "Interleukin-22(IL-22)activates the JAK", STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10, 2002, pp.277, 33676~33682
10. Arshad T, "A double edged sword role of interleukin-22 in wound healing and tissue regeneration", Front Immunol, 11, pp.2148~ (2020)
11. Wolk K, "IL-22 increases the innate immunity of tissues", Immunity, 21, pp.241~254 (2004)
12. Lücke J, "The good and the bad about separation anxiety : roles of IL-22 and IL-22BP in liver pathologies", Semin Immunopathol, 43, pp.591~607 (2021)
13. Sabat R, "Therapeutic opportunities of the IL-22-IL-22R1 system", Nat Rev Drug Discov, 13, pp.21~38 (2014)
14. Arab JP, "An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis", Hepatology, 72, pp.441~453 (2020)
15. Gao B, "Interleukin-22 from bench to bedside : a promising drug for epithelial repair", Cell Mol Immunol, 16, pp.666~667 (2019)
16. Mizoguchi A, "Clinical importance of IL-22 cascade in IBD", J Gastroenterol, 53, pp.465~474 (2018)
17. Wei HX, "IL-10 and IL-22 in mucosal immunity : driving protection and pathology", Front Immunol, 11, pp.1315~ (2020)
18. Lindemans CA, "Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration", Nature, 528, pp.560~564 (2015)
19. Sugimoto K, "IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis", J Clin Invest, 118, pp.534~544 (2008)
20. Pickert G, "STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing", J Exp Med, 206, pp.1465~1472 (2009)
21. Qiu Y, "Lactobacillus plantarum enhanced IL-22 production in natural killer(NK)cells that protect the integrity of intestinal epithelial cell barrier damaged by enterotoxigenic Escherichia coli", Int J Mol Sci, 18, pp.2409~ (2017)
22. Mizoguchi A, "Healing of intestinal inflammation by IL-22", Inflamm Bowel Dis, 18, pp.1777~1784 (2012)
23. Ray K, "Stem cells : IL-22 activates ISCs for intestinal regeneration", Nat Rev Gastroenterol Hepatol, 13, pp.64~ (2016)
24. Saxton RA, "The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based design", Immunity, 54, pp.660~672 (2021)
25. Mihi B, "Interleukin-22 signaling attenuates necrotizing enterocolitis by promoting epithelial cell regeneration", Cell Rep Med, 2, pp.100320~ (2021)
26. Yu L, "Molecular characteristics of rhesus macaque interleukin-22 : cloning, in vitro expression and biological activities", Immunology, 154, pp.651~662 (2018)
27. Niv-Spector L, "Preparation and characterization of mouse IL-22 and its four single-amino-acid muteins that act as IL-22 receptor-1antagonists", Protein Eng Des Sel, 25, pp.397~404 (2012)
28. Feng Y, "An automatic refolding apparatus for preparative-scale protein production", PLoS One, 7, pp.e45891~ (2012)
29. Kwon J, "A combination strategy of solubility enhancers for effective production of soluble and bioactive human enterokinase", J Biotechnol, 340, pp.57~63 (2021)
30. Zhang L, "Disulfide bond formation and its impact on the biological activity and stability of recombinant therapeutic proteins produced by Escherichia coli expression system", Biotechnol Adv, 29, pp.923~929 (2011)
31. Xu F, "A rapid bioassay for recombinant interleukin-22", J Immunoassay Immunochem, 31, pp.71~78 (2010)
32. de Oliveira Neto M, "Interleukin-22 forms dimers that are recognized by two interleukin-22R1receptor chains", Biophys J, 94, pp.1754~1765 (2008)
33. Rosano GL, "Recombinant protein expression in Escherichia coli : advances and challenges", Front Microbiol, 5, pp.172~ (2014)
34. Arnau J, "Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins", Protein Expr Purif, 48, pp.1~13 (2006)
35. Brand S, "IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration", Am J Physiol Gastrointest Liver Physiol, 290, pp.G827~G838 (2006)
36. Pithadia AB, "Treatment of inflammatory bowel disease(IBD)", Pharmacol Rep, 63, pp.629~642 (2011)
37. Ungaro R, "Ulcerative colitis", Lancet, 389, pp.1756~1770 (2017)
38. Kane SV, "Systematic review : adherence issues in the treatment of ulcerative colitis", Aliment Pharmacol Ther, 23, pp.577~585 (2006)
39. Collins P, "Ulcerative colitis : diagnosis and management", BMJ, 333, pp.340~343 (2006)
40. Zenlea T, "Immunosuppressive therapies for inflammatory bowel disease", World J Gastroenterol, 20, pp.3146~3152 (2014)
41. Keir M, "The role of IL-22 in intestinal health and disease", J Exp Med, 217, pp.e20192195~ (2020)
42. Zenewicz LA, "Recent advances in IL-22 biology", Int Immunol, 23, pp.159~163 (2011)
43. Pelczar P, "A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease", Science, 354, pp.358~362 (2016)
44. Pham TA, "Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen", Cell Host Microbe, 16, pp.504~516 (2014)
45. Cox JH, "Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice", Mucosal Immunol, 5, pp.99~109 (2012)
46. Stefanich EG, "Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases", Biochem Pharmacol, 152, pp.224~235 (2018)
47. Eken A, "IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism", Mucosal Immunol, 7, pp.143~154 (2014)
48. Rothenberg ME, "Randomized phase I healthy volunteer study of UTTR1147A(IL-22Fc) : a potential therapy for epithelial injury", Clin Pharmacol Ther, 105, pp.177~189 (2019)
49. Zenewicz LA, "Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease", Immunity, 29, pp.947~957 (2008)
50. Monteleone I, "Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract", Gastroenterology, 141, pp.237~248 (2011)
51. Zindl CL, "IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis", Proc Natl Acad Sci U S A, 110, pp.12768~12773 (2013)
52. Tsai PY, "IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance", Cell Host Microbe, 21, pp.671~681 (2017)
53. Zhang X, "Interleukin-22 regulates the homeostasis of the intestinal epithelium during inflammation", Int J Mol Med, 43, pp.1657~1668 (2019)
54. Powell N, "Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells", Gut, 69, pp.578~590 (2020)
55. Wu T, "Elevated serum IL-22 levels correlate with chemoresistant condition of colorectal cancer", Clin Immunol, 147, pp.38~39 (2013)
56. Ma HL, "IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation", J Clin Invest, 118, pp.597~607 (2008)
57. Shohan M, "Interleukin-22 and intestinal homeostasis : protective or destructive", IUBMB Life, 72, pp.1585~1602 (2020)
58. Kim K, "Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation", Carcinogenesis, 35, pp.1352~1361 (2014)
59. Zhang Y, "IL-22 promotes tumor growth of breast cancer cells in mice", Aging(Albany NY), 12, pp.13354~13364 (2020)
60. Loera-Arias MJ, "Secretion of biologically active human interleukin 22(IL-22)by Lactococcus lactis", Biotechnol Lett, 36, pp.2489~2494 (2014)
61. de Moura PR, "Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22", FEBS Lett, 583, pp.1072~1077 (2009)

관련 논문AI추천